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Abstract 
 
Objective: To review the range of patient reported outcome measures (PROMs) 
used in clinical studies of patients with oral lichen planus (OLP) and to assess their 
psychometric properties and interpretability. 
Methods: Literature searches were performed on MEDLINE, Embase and Web of 
Science databases (1990 - September 2016) to retrieve relevant studies related to 
the development, psychometric testing and/or use of PROMs assessing oral 
symptoms, psychosocial status, and quality of life in individuals with OLP. The 
identified PROMs were then categorized by concept measured and assessed for 
instrument characteristics and evidence for psychometric properties and 
interpretability. 
Results: We identified a total of 41 PROMs used in clinical studies for the 
assessment of patient reported outcomes in patients with OLP. There were 3 
PROMs of oral symptoms, 30 PROMs of psychosocial status and 8 PROMs of 
quality of life. Six instruments (Visual Analog Scale, Numerical Rating Scale, Change 
in Symptom Scale, Oral Health Impact Profile-14, Oral Health related Quality of Life-
UK and Chronic Oral Mucosal Disease Questionnaire) demonstrated  some 
evidence of psychometric properties but no evidence for interpretability of their 
results in the OLP population.  
Conclusion: The range of PROMs used in clinical studies of patients with OLP is 
wide and include instruments for oral symptoms, psychosocial status and quality of 
life. The vast majority of these instruments have no evidence of psychometric 
properties and interpretability for patients with OLP. Further qualitative and validation 
studies are required to investigate whether these instruments are appropriate for use 
in this patient population.  
  
Introduction 
 
Over the past few decades, there has been a substantial increase in the 
development, validation and application of patient reported outcome measures 
(PROMs) for research and/or clinical practice (1). A PROM is a standardized 
instrument (usually a questionnaire) for patients to directly evaluate one or more 
aspects of their own health (2). The aim is to quantify, evaluate and monitor the 
subjective perception of the impact of the disease from patient’s perspective in a 
standardized way, and to incorporate the patient’s voice regarding the perception of 
their health condition and related treatment into clinical practice and research (2). 
PROMs are required to have adequate psychometric properties as well as good 
evidence for interpretability for the specific patient population. From the perspective 
of clinical research, a vital step in the design of clinical trial is to select a PROM with 
appropriate psychometric properties to ensure that the instrument is suitable for its 
proposed application, valid (measure what it is intended to measure), reliable 
(produce consistent results on repeated measurement under identical conditions) 
and responsive (able to detect change over time) in a specific group of patients (3). 
Further to the psychometric properties, it is necessary that scores or outcomes 
generated by the PROMs are interpretable or clinically meaningful (3).  
 
Little is known regarding the use of PROMs in patients with oral lichen planus (OLP), 
a common chronic inflammatory disease (4, 5) that can cause long-standing painful 
ulceration of the oral mucosa (6, 7) and is also known to increase the risk of oral 
cancer development (8). The persistent painful symptoms of OLP can have 
significant negative impact on daily activities (e.g. eating, swallowing, speaking) but 
can also impair psychosocial functioning as well as patient’s quality of life (9). 
Therefore medical treatment, often in the form of long-term use of topical 
corticosteroids or immunosuppressants, is required to reduce patient's painful 
symptoms (10).  
 
Clinical scoring systems (CSS) used in OLP have been comprehensively addressed 
in a recent review (11). Some of these CSS demonstrated good measurement 
properties for use in clinical studies of patients with OLP including Escudier severity 
scale (ESS) (12) and Reticulation-Erythema-Ulceration (REU) scoring system (13, 
14). However, very few studies focus mainly on the use and psychometric evidence 
of PROMs in OLP patients. Two reviews have previously investigated the use of 
PROMs in patients with oral mucosal diseases (15, 16), but there remains no 
comprehensive assessment of the instruments used specifically in studies of OLP 
patients.  The purposes of the present study are to 1) review the range of PROMs 
used for the assessment of oral symptoms, psychosocial status, and quality of life in 
the OLP population and 2) assess their psychometric properties and interpretability. 
 
Methods 
 
Literature search 
Search strategies for this review were designed to retrieve articles related to the use 
of PROMs for the assessment of oral symptoms, psychosocial status and quality of 
life in patients with OLP. Electronic searches of literature on the MEDLINE (through 
PubMed), Embase and Web of Science Citation Index were performed. The 
following search terms were applied for each domain of concept.  
 1. Oral symptoms: ‘oral lichen planus’ AND ‘pain’, ‘burning sensation’, ‘symptom*’ 
2. Psycho-social status: ‘oral lichen planus’ AND ‘psych*’, ‘anxiety’, ‘depress*’, 
‘stress’, ‘mood’, ‘emotion*’, ‘social’ 
3. Quality of life: ‘oral lichen planus’ AND ‘quality of life’, ‘oral health related quality of 
life’ 
 
Searches in each concept were initially limited to the literature from 1990 until 2016 
based on substantial rise in the development and validation of PROMs since 1990 
(17). However, due to the large number of articles related to the use of PROMs 
assessing symptoms in OLP population, we refined the scope of time frame to a 
period of 10 years (2007-2016) in the search of OLP studies evaluating symptoms.  
 
Selection criteria 
Articles were included in this review if they fulfilled the following criteria: publication 
in the English language and in a peer-reviewed journal; full text available; and 
reporting on the development, psychometric testing and/or application of at least one 
PROM for the assessment of oral symptoms, psychosocial status and quality of life 
in patients with OLP.  
 
Exclusion criteria included: the use of PROMs as a screening tool rather than for 
study outcome measurement; the use of ad hoc instrument or instrument developed 
without psychometric testing for specific use in one study; literature reviews, 
editorials and letters.  
 
Data extraction 
A specific data extraction form was employed to systematically extract the data of 
interest from each article including study title, authors and year of publication, 
country, study design and type of intervention, number of participants, participant 
characteristics (female-to-male ratio, age, clinical type of OLP) and type of PROMs 
used. All identified PROMs were categorized into three groups based on the 
concepts they aimed to measure: oral symptoms, psychosocial status, and quality of 
life. Their number of items, subscales or domains, rating scales and score types and 
range were reviewed. In addition, all PROMs were investigated for evidence of 
psychometric testing as well as interpretability for the application in patients with 
OLP.   
 
The assessment of psychometric testing and interpretability of identified PROMs 
included 
1. Validity: the degree to which a PROM measures the construct(s) it purports to 
measure.  The assessment of validity includes  
- Content validity: the extent to which the content of a PROM adequately 
reflects the proposed construct to be measured. 
- Construct validity: the extent to which a PROM validly measures the 
‘construct’ or the theoretical concept that it purports to measure. 
- Criterion validity: the extent to which the scores of a PROM adequately 
relate to another ‘criterion’ measure that is considered to be a ‘gold 
standard’ in the field of study. 
2. Reliability: the degree to which the measurement is free from measurement 
error. The assessment of reliability includes 
-  Test-retest reliability: the extent to which the same results are obtained on 
repeated measurement of the same PROM when no change in patient’s 
status has occurred. 
-  Internal consistency reliability: the degree of the interrelatedness among  
the items. 
3. Responsiveness: the ability of a PROM to detect change over time in the 
construct measured. 
4. Interpretability: the degree to which one can assign qualitative meaning to an 
instrument's quantitative scores or change in scores (3). 
 
Results 
 
Search results 
The initial literature search yielded a total of 2,942 citations. After removing 
duplicates and spurious references, and following a review of the titles and abstracts, 
120 articles were considered to meet the inclusion criteria (Figure 1). A total of 41 
PROMs were identified from these 120 publications (detailed in Table 1).  
 
PROMs assessing oral symptoms of OLP 
Three generic PROMs were identified from 81 studies: the visual analog scale 
(VAS), the numerical rating scale (NRS) and the change in symptoms scale (CSS). 
The majority of studies (75/81, 92.59%) used the VAS while the NRS and CSS were 
used in seven (8.64%) and two studies (2.47%) respectively. Interestingly, word 
descriptors for the VAS varied among studies including “pain” (used 49 times; in 
65.33% of studies), “pain and/or burning sensation” (used 12 times; in 16% of 
studies), discomfort, taste dysfunction, and many others (Table 2). Out of the 
seventy-five OLP studies using the VAS, less than 50% (33/75, 44%) provided clear 
and accurate information, in the relevant material and methods section, regarding 
the use of the instrument and the measurement of results; twenty-five articles 
(33.3%) reported incorrect or unclear information while seventeen articles (22.67%) 
did not provide any information. 
 
PROMs assessing psychosocial status in OLP patients 
A total of 30 PROMs assessing psychosocial status in OLP patients were identified 
from 29 studies. All of them were generic instruments (Table 3). The most commonly 
used instruments were the State-Trait Anxiety Inventory (STAI; 9 studies), followed 
by the Beck Depression Inventory (BDI; 7 studies) and the Hospital Anxiety and 
Depression Scale (HADS; 7 studies).  
 
PROMs assessing the quality of life of OLP patients 
A total of 8 PROMs focusing upon quality of life in patients with OLP were identified 
from 27 studies. Six of these PROMs were oral health-related quality of life (OH-
QoL) instruments; the other two were general quality of life instruments (SF-36 and 
SF-12). Out of the six OH-QoL instruments, two were developed for specific group of 
patients: individuals with head and neck cancer (UW-QOL) and with chronic oral 
mucosal diseases (COMDQ). Table 4 provides characteristics of these instruments. 
The most frequently used quality of life PROMs in the OLP population was the Oral 
Health Impact Profile-14 (OHIP-14; 11 studies), followed by the Oral Health Impact 
Profile-49 (OHIP-49; 6 studies) and the Medical Outcome Study Short Form 36 
Health Survey (SF-36; 3 studies). 
 Evidence for psychometric properties and interpretability of identified PROMs 
With respect to PROMs of oral symptoms, we found one study assessing the 
psychometric properties of VAS, NRS and CSS in the OLP population (18), and no 
study assessing interpretability of these PROMs in this patient population was found.  
 
There was no evidence of psychometric testing or interpretability on any of the 
PROMs relevant to the psychosocial status of OLP individuals. 
 
Three out of eight quality of life PROMs had their psychometric properties tested 
including OHIP-14, OHQoL-UK and COMDQ but none of these instruments have 
evidence for the interpretability of their results. Table 5 summarises the psychometric 
testing of the reviewed PROMs. 
 
Discussion 
 
Oral lichen planus can give rise to longstanding painful symptoms to the oral 
mucosa, often leading to psychological distress and a reduction in the quality of life 
(19-21). Patient reported outcome measures are crucial in assessing the effect of the 
disease and its treatment, as perceived by the affected patients, and provide 
complementary information to the clinician-based clinical assessment of the 
condition (2). A wide range of PROMs has been used in clinical studies of OLP 
patients; however, there remains no comprehensive review of these instruments 
and, more importantly, there is no thorough critical assessment of their psychometric 
properties and interpretability. As a consequence little guidance is available for 
clinicians as regards to which instruments have been appropriately validated and 
therefore could be used for treatment and research of OLP.   
 
In the present study three PROMs (VAS, NRS and CSS) were identified that have 
been used to assess oral symptoms of OLP, with VAS being the most common. 
However there was a wide variability and lack of consistency in the type of oral 
symptoms measured by this instrument, as reflected by a number of different 
descriptors including “pain”, “pain at rest”, “discomfort”, “burning sensation” and 
many others (Table 2). This heterogeneity makes study comparison and data pooling 
difficult. We also found that the material and method sections of the reviewed studies 
provided the necessary information (22, 23) about the use and interpretation of the 
VAS only in 44% of instances. In the remaining studies information on VAS were 
either absent or incorrect; for example one study stated that “patients rated their 
symptoms on a scale from 0 to 10”, which appear to reflect NRS rather than VAS.  
 
Both VAS and NRS have been validated in patients with OLP resident in the US by 
Chainani-Wu et al (2008) (18), who reported better construct validity in NRS than in 
VAS, as demonstrated by higher correlations with clinical manifestations. Other 
strengths of NRS over VAS include its simplicity of scoring, better compliance owing 
to its comprehensibility and ease of completion, as well as the fact that it can be 
used in greater variety of patients including the elderly and those with motor 
problems (24). Therefore, NRS may be considered a better instrument than VAS for 
the measurement of oral symptoms in the OLP population. We did not find any 
studies providing information regarding the interpretability of PROMs of oral 
symptoms in the OLP population, which raises concerns regarding the clinical 
meaning of their results (3, 25, 26).  
 
Our review identified a wide range of PROMs focusing on the psychosocial status of 
OLP patients. Studies have used instruments relevant to psychological constructs 
(anxiety, depression, stress, distress, coping with illness, hardiness, health locus of 
control, psychological symptoms and well-being, spirituality and vulnerability), as well 
as emotional (mood, emotion regulation, anger, loneliness) and social constructs 
(social support).  
 
Anxiety and depression were the most frequently assessed psychosocial concepts in 
OLP population, and STAI, BDI and HADS were the most commonly used PROMs in 
OLP studies. All three instruments have demonstrated good psychometric properties 
in a general population (27-29); however, all of them lack psychometric evidence in 
OLP samples. Instruments focusing upon other psychosocial constructs were few 
(30, 31) and, again there was no evidence of their psychometric testing or 
interpretability in the OLP population. Overall, the present findings raise concerns as 
to whether these instruments are indeed relevant, comprehensive, valid and reliable 
for capturing the psychosocial status of individuals with OLP. Nonetheless HADS 
may have a potential to be a PROM of choice for use in patients with OLP as it 
comprises 14 simple-to-follow items with detailed, straightforward instruction (29) 
and can capture both anxiety and depression, whereas STAI and BDI have more 
questions, require more time to complete and provide information on only one 
psychological concept.  
 
Assessment of quality of life in OLP individuals is important as it reflects the patient’s 
subjective perception of the impact of a disease and related treatment on physical, 
psychological and social aspects of life (32, 33). A number of quality of life PROMs 
have been used in patients with OLP, and can be divided into instruments assessing 
oral health-related quality of life (OH-QoL) and those assessing general aspects of 
quality of life.  
 
Our review identified six OH-QoL PROMs, but only three have had their 
psychometric properties tested in the OLP population: the OHIP-14, OHQOL-UK and 
COMDQ. OHIP-14 is the most frequently used PROMs for the assessment of quality 
of life in OLP literature. This was initially developed for use in older Australian adults 
and is a shortened version of the original OHIP-49 containing 14 items with a subset 
of 2 questions for each of the 7 domains of OH-QoL, which is based upon Locker’s 
conceptual framework of oral health (34, 35). OHQOL-UK was developed upon adult 
UK population’s perceptions of how oral health affects quality of life (36). Therefore 
both OHIP-14 and OHQOL-UK were developed without the input from patients with 
OLP and therefore may not be able to capture all relevant aspects associated with 
the disease and related treatment. COMDQ is an oral medicine-specific PROM 
developed for the assessment of quality of life in patients with chronic oral mucosal 
disease (37). It is the only validated PROM that was developed with input from 
patients with OLP. In addition, COMDQ has the highest number of validation studies 
of patients with OLP compared to the other OH-QoL PROMs. Regarding the 
measurement of general aspect of quality of life, only two PROMs have been used in 
studies of OLP patients including SF-36 and SF-12. Neither of them had their 
psychometric properties or interpretability tested in the OLP population.  
 This review found that there are no studies reporting the interpretability of PROMs in 
patients with OLP. Interpretability gives meaning to the scores from these 
instruments in a clinical context, which facilitates better understanding of PROM 
results (3, 26). The numerical scores derived from PROMs should be easily 
translated into clinically meaningful information, relevant to patients, clinicians and 
researchers. An interpretability parameter such as the minimal important difference 
(MID), the smallest magnitude of change in PROM scores which constitutes a 
clinically meaningful change (26, 38), can therefore facilitate the translation of these 
scores. There is thus a need for further studies determining interpretability of PROMs 
in patients with OLP. 
 
The treatment of OLP is not curative, rather the goal is to minimise symptoms and 
improving patient’s quality of life. Although a wide array of topical and systemic 
medications are available for patients with OLP, there is currently weak evidence 
supporting the superiority of any of these medications over placebo (12, 39), and 
future large randomized placebo-controlled trials (RCTs) are needed. These RCTs 
will require the careful selection of validated outcome measures, both clinical 
measures and PROMs. Although the present study identified some promising 
PROMs in several patient-reported concepts with appropriate psychometric 
properties for use in clinical studies of patients with OLP, there is currently a lack of 
uniformity in the choice of outcome measures including both PROMs and clinical 
measures of signs and disease activity (11) across the OLP literature. Therefore 
there is an urgent need for a consensus on the core outcome set for clinical trials of 
OLP.  This could enhance the quality of future clinical research, leading to more 
robust evidence supporting the use of OLP medications and eventually better patient 
care.  
 
Conclusions  
A wide range of PROMs have been used in clinical studies of OLP patients. 
However, as there is little convincing evidence regarding their psychometric 
properties and interpretability in patients with OLP. Concerns exist about their 
appropriateness as well as the clinical meaningfulness of their results. Furthermore, 
our review showed a high heterogeneity among published studies in the use of 
PROMs in OLP population. There is therefore an urgent need to establish a core set 
of PROMs OLP to be used in clinical trials, so to allow comparison of interventions 
and data pooling in systematic reviews and meta-analyses. 
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Table 1 Types (by concepts measured), acronyms and frequency of use of PROMs in 
clinical studies of patients with OLP 
Instrument type and name frequency of use 
PROMs assessing oral symptoms  
  Symptoms  
    Visual Analog Scale (VAS) 75 
    Numerical Rating Scale (NRS) 7 
    Change in Symptoms Scale (CSS) 2 
PROMs assessing psychological status  
  Anxiety (only)  
    State-Trait Anxiety Inventory (STAI) 9 
    Beck Anxiety Inventory (BAI) 1 
  Depression (only)  
    Beck Depression Inventory (BDI) 7 
    Centre for Epidemiologic Studies Depression Scales (CES-D) 1 
  Stress (only)  
    Perceived Stress Questionnaire (PSQ) 2 
    Perceived Stress Scale (PSS) 2 
    Lipp's Inventory of Stress Symptoms of Adults (LISS) 1 
    Social Readjustment Rating Scale (SRRS) 1 
    Test of Recent Experience (TRE) 1 
  Anxiety and depression  
    Hospital Anxiety and Depression Scale (HADS) 7 
  Anxiety, depression and stress  
    Depression, Anxiety and Stress Scale (DASS-42) 3 
  Anxiety, depression and vulnerability  
    Hassanyeh Rating of Anxiety-Depression-Vulnerability (Hassanyeh RADV) 1 
  Distress/psychological symptoms  
    Brief Symptom Inventory (BSI) 1 
    General Health Questionnaire-12 (GHQ-12) 1 
    General Health Questionnaire-28 (GHQ-28) 1 
    Self Reporting Questionnaire (SRQ) 1 
    Symptom Checklist (SCL-90) 1 
  Coping  
    Coping Orientation to Problems Experienced Inventory (COPE) 1 
    Freiburg Questionnaire on Coping with Illness-short form (FKV-LIS) 1 
    Ways of Coping Questionnaire (WCQ) 1 
  Hardiness  
    Hardiness Scale  1 
  Health locus of control  
    Health/Illness Locus of Control Questionnaire (KKG) 1 
  Psychological well-being  
    Psychological General Well-being Index-short form (PGWBI-S) 1 
  Spirituality  
    Systems of Belief Inventory (SBI-14-R-D) 1 
 
Table 1 Types (by concepts measured), acronyms and frequency of use of PROMs 
in clinical studies of patients with OLP (cont) 
Instrument type and name frequency of use 
PROMs assessing emotional impacts  
  Mood  
    Mood Adjective Check List (MACL) 1 
    Profile of Mood States Questionnaire (POMS) 1 
  Anger  
    State-Trait Anger Expression Inventory (STAXI-2) 1 
  Emotion regulation  
    Multidimentional Negative Emotions Self-Regulatory Efficacy Scale (MNESRES) 1 
  Loneliness  
    UCLA Loneliness Scale 1 
PROMs assessing social impacts  
  Social support  
    Social Support Questionnaire-short form (F-SozU-K22) 1 
PROMs assessing quality of life  
  Oral health related quality of life  
    Oral Health Impact Profile-14 (OHIP-14) 12 
    Oral Health Impact Profile-49 (OHIP-49) 6 
    Oral Health-Related Quality of Life-UK (OHQOL-UK) 2 
    Oral Health Impact Profile-German version (OHIP-G) 1 
  Oral health related quality of life specific to chronic oral mucosal diseases  
    Chronic Oral Mucosal Disease Questionnaire (COMDQ) 2 
  Health related quality of life specific to head and neck cancer  
    University of Washington Quality of Life Questionnaire-version 4 (UWQOL V4) 1 
  General health related quality of life  
    Medical Outcome Study Short Form 36 Health Survey (SF-36) 3 
    Medical Outcome Study Short Form 12 Health Survey (SF-12) 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Word descriptors used in VAS in the studies assessing oral symptoms of OLP 
Word descriptors frequency 
pain 49 
pain and/or burning sensation 12 
burning sensation 5 
oral symptoms 4 
pain and/or discomfort 3 
taste function/disorder 2 
breath odor 1 
discomfort 1 
dry mouth 1 
loss of appetite 1 
oral freshness 1 
pain at rest 1 
pain at meal time 1 
postoperative pain 1 
spontaneous pain 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Characteristics of PROMs assessing psychosocial status in clinical studies of patients with OLP 
  Name Items 
(N) Concept Subscale (N items) 
Rating 
scale 
Score types and range 
 Subscales Total Others 
  BAI 21 Anxiety Anxiety (21) 4-point scale 
(0-1-2-3)  
0-63  
  BDI, BDI-II 21 Depression Depression (21) 4-point scale 
(0-1-2-3)  
0-63  
  BSI 53 Psychological 
 symptoms 
Somatisation (SOM); Obsessive-compulsive behavior (O-C); Interpersonal sensitivity (I-S); 
Depression (DEP); Anxiety (ANX); Hostility (HOS); Phobic anxiety (PHOB); Paranoid 
ideation (PAR); Psychoticism (PSY) 
5-point scale 
(0-1-2-3-4) 
✓  GSI* 
PST* 
PSDI* 
  CES-D 20 Depression Depressive affect (7); Positive affect (4); Somatic and retarded activity (7); Interpersonal 
(2) 
4-point scale 
(0-1-2-3)  
0-60  
  COPE 60 Coping Positive reinterpretation and growth (4); Mental disengagement (4); Focus on and venting 
of emotions (4); Use of instrumental social support (4); Active coping (4); Denial (4); 
Religious coping (4); Humor (4); Behavioural disengagement (4); Restraint (4); Use of 
emotional social support (4); Substance use (4); Acceptance (4); Suppression of 
competing activities (4); Planning (4) 
4-point scale 
(0-1-2-3) 
 4-16   
  DASS-42 42 Anxiety,  
depression, 
stress 
Anxiety (14); Depression (14); Stress (14) 4-point scale 
(0-1-2-3) 
0-42   
  FKV-LIS 35 Coping Depressive coping; Active problem-oriented coping; Distraction and self-motivation; 
spirituality; Minimisation and wishful thinking 
5-point scale 
(1-2-3-4-5) 
✓ 
(mean of all 
subscale items) 
  
  F-SozU-K22 22 Social 
support 
Emotional support; Practical support; Social integration 5-point scale 
(1-2-3-4-5) 
✓ 
(mean of all 
subscale items) 
22-110  
  GHQ-12 12 Distress Distress (12) 4-point scale 
(0-0-1-1 or  
0-1-2-3) 
 0-12  
0-36  
  GHQ-28 28 Distress Somatic symptoms (7); Anxiety and insomnia (7); Social dysfunction (7); Severe 
depression (7) 
4-point scale 
(0-0-1-1 or  
0-1-2-3) 
0-7 
0-21 
0-28 
0-84  
  HADS 14 Anxiety,  
depression 
Anxiety (HADS-A) (7); Depression (HADS-D) (7) 4-point scale 
(0-1-2-3) 
0-21   
  Hardiness   
   Scale 
45 Hardiness Control (15); Commitment (15); Challenge (15) 4-point scale 
(0-1-2-3) 
0-45 0-135  
  Hassanyeh   
   RADV 
68 Anxiety,  
depression, 
vulnerability 
Anxiety (AN) (17); Global depression (GD) (47); Vulnerability or Personality Predisposition 
(PD) (16) 
2-point scale 
(0-1) 
N/A   
  KKG 21 Health locus  
 of control 
Internality (7); Powerful other externality (7); Chance externality (7) 6-point scale 
(1-2-3-4-5-6) 
✓ 
(mean of all  
subscale items) 
  
  LISS 56 Stress Phase: Alert (Q1) (16); Resistance amd  Near-exhaustion (Q2) (16); Exhaustion (Q3) (24) 2-point scale 
(0-1) 
0-15 (Q1, 2) 
0-23 (Q3)   
  MACL 72 Mood Pleasantness/unpleasantness; Activation/deactivation; Extraversion/introversion; 
Calmness/tension; Positive/negative social orientation; Control/lack of control 
4-point scale 
(0-1-2-3) 
N/A     
 
Table 3 Characteristics of PROMs assessing psychosocial status in clinical studies of patients with OLP 
Name Items 
(N) Concept Subscale (N items) 
Rating scale Score types and range 
 Subscales Total Others 
  MNESRES 15 Emotion  
 regulation 
Perceived self-efficacy in dealing with negative emotions: Anger/irritation (3); 
Despondency/sadness (3); Fear (3); Shame/embarrassment (3); Guilt (3) 
5-point scale 
(1-2-3-4-5) 
3-15   
  PGWBI-S 6 Psychological 
 well-being 
Anxiety (1); Vitality (2); Depressed mood (1); Self-control (1); Positive well-being (1) 6-point scale 
(0-1-2-3-4-5) 
✓ 0-30  
  POMS 65 Mood Tension (T) (9); Depression (D) (15); Anger (A) (12); Fatigue (F) (7); Confusion (C) (7); 
Vigour (V) (8) 
5-point scale 
(0-1-2-3-4) 
✓  TMD* 
  PSQ 20 Stress Worries (5); Tension (5); Joy (5); Demands (5) 4-point scale 
(1-2-3-4)  
20-80  
  PSS 10 Stress Perceived stress (10) 5-point scale 
(0-1-2-3-4)  
0-40  
  SBI-15-R-D 15 Spirituality Belief and practice (10); Social support (5) 4-point scale 
(0-1-2-3)  
0-45  
  SCL-90 90 Psychological 
 symptoms 
Somatisation (SOM); Obsessive-compulsive behavior (O-C); Interpersonal sensitivity (I-S); 
Depression (DEP); Anxiety (ANX); Hostility (HOS); Phobic anxiety (PHOB); Paranoid 
ideation (PAR); Psychoticism (PSY) 
5-point scale 
(0-1-2-3-4) 
✓  GSI* 
PST* 
PSDI* 
  SRQ-20 20 Psychological 
 symptoms 
Mental health (20) 2-point scale 
(0-1)  
0-20  
  SRRS 43 Stress Stressful life events (43) 2-point scale 
(0-life change 
units) 
 ✓ 
(total life 
change 
units) 
No of 
events 
  STAI 40 Anxiety State anxiety (STAI-S) (20); Trait anxiety (STAI-T) (20) 4-point scale 
(1-2-3-4) 
20-80   
  STAXI-2 57 Anger State anger (S-Anger) (15) (Feeling angry, S-Ang/F; Feel like expressing anger verbally, S-
Ang/V; Feel like expressing anger physically, S-Ang/P); Trait anger (T-Anger) (10) (Angry 
temperament, T-Ang/T; Angry reaction, T-Ang/R); Anger expression-out (AX/Out) (8); 
Anger expression-in (AX/In) (8); Anger control-out (AX/Con-Out) (8); Anger control-in 
(AX/Con-In) (8); Anger expression index (AX index) (32) 
4-point scale 
(1-2-3-4) 
✓  AX index* 
(0-96) 
  TRE 42 Stress Vital events (42) 2-point scale 
(0-life change 
units) 
 0-600  
  UCLA  
   Loneliness  
   Scale  
20 Loneliness Loneliness (20) 4-point scale 
(1-2-3-4)  
20-80  
  WCQ 66 Coping Confrontive coping (6); Distancing (6); Self-controlling (7); Seeking social support (6); 
Accepting responsibility (4); Escape-Avoidance (8); Planful problem solving (6); Positive 
reappraisal (7) 
4-point scale 
(0-1-2-3) 
✓     
*Abbreviation: AX index = AX/Out + AX/In – (AX/Con-Out + AX/Con-In) + 48; GSI = Global Severity Index (mean of all subscale scores); PST = Positive Symptom Total (number of items 
with score > 0); PSDI = Positive Symptom Distress Index (the sum of all item values divided by PST); TMD = Total Mood Disturbance ([Tension + Depression + Anger + Fatigue + 
Confusion] - Vigour) 
 
 
 
Table 4 Characteristics of PROMs assessing quality of life in clinical studies of patients with OLP 
Name Items 
(N) Concept Subscale (N items) 
Rating scale Score types and range 
 Subscales Total Others 
  COMDQ 26 OH-QOL 
 specific to  
 COMD 
Pain & function limitation (PF) (9); Medication & treatment (MT) (6);  
Social & emotional (SE) (7); Patient support (PS) (4) 
5-point scale 
(0-1-2-3-4) 
0-36 for PF  
0-24 for MT 
0-28 for SE 
0-16 for PS 
0-104  
  OHIP-14 14 OH-QOL Functional limitation (FL) (2); Physical pain (PhyP) (2); Psychological discomfort (PsyD) 
(2); Physical disability (PhyDis) (2); Psychological disability (PsyDis) (2); Social disability 
(SDis) (2); Handicap (H) (2) 
5-point scale 
(0-1-2-3-4)  
0-56 
(Severity) 
Extent* 
  OHIP-49 49 OH-QOL Functional limitation (FL) (9); Physical pain (PhyP) (9); Psychological discomfort (PsyD) 
(5); Physical disability (PhyDis) (9); Psychological disability (PsyDis) (6); Social disability 
(SDis) (5); Handicap (H) (6) 
5-point scale 
(0-1-2-3-4) 
0-36 for  
FL, PhyP, PhyDis 
0-24 for PsyDis, H   
0-20 for PsyD, 
SDis  
0-196  
  OHIP-G 53 OH-QOL Functional limitation (FL) (9); Physical pain (PhyP) (9); Psychological discomfort (PsyD) 
(5); Physical disability (PhyDis) (9); Psychological disability (PsyDis) (6); Social disability 
(SDis) (5); Handicap (H) (6); Additional German Items (AGI) (4) 
5-point scale 
(0-1-2-3-4) 
0-36 for  
FL, PhyP, PhyDis 
0-24 for PsyDis, H   
0-20 for PsyD, 
Sdis 
0-16 for AGI  
0-212  
  OHQOL-UK 16 OH-QOL Physical effects/impacts (Phy-E/I) (6); Social effects/impacts (S-E/I) (5); Psychological 
effects/impacts (Psy-E/I) (5) 
5-point scale (1-
2-3-4-5 for 
effects and 0-1-
2-3-4 for 
impacts) 
6-54 for Phy-E/I 
5-45 for S-E/I, 
Psy-E/I 
16-144  
  SF-12 12 GH-QOL Physical functioning (PF) (2); Role physical (RP) (2); Bodily pain (BP) (1); General health 
(GH) (1); Vitality (VT) (1); Social functioning (SF) (1); Role emotional (RE) (2); Mental 
health (MH) (2) 
2- to 6-point 
scale   
PCS-12 
MCS-12 
  SF-36 36 GH-QOL Physical functioning (PF) (10); Role physical (RP) (4); Bodily pain (BP) (2); General 
health (GH) (5); Vitality (VT) (5); Social functioning (SF) (2); Role emotional (RE) (3); 
Mental health (MH) (5); Health transition (HT) (1) 
2- to 6-point 
scale 
0-100 
(transformed 
 from raw score) 
0-100 
(transformed 
 from raw 
score) 
PCS* 
MCS* 
  UWQOL-V4 16 H-QofL  
 specific to   
 H&N 
cancer 
Domain: Pain (1); Appearance(1); Activity (1); Recreation (1); Swallowing (1); Chewing 
(1); Speech (1); Shoulder (1); Taste (1); Saliva (1); Mood (1); Anxiety (1) 
Importance rating (1) 
Global score: HRQofL compared to mouth before had cancer (1); HRQofL during the 
past 7 days (1); Overall QofL during the past 7 days (1) 
 
3- to 6-point 
scale 
0-100   Physical  
 subscale   
 score* 
Social-  
Emotional 
 subscale  
 score* 
*Note: Extent = N of items reported fairly often (3)/very often (4); GH-QOL = general health related quality of life; H-QOL = health related quality of life; OH-QOL = oral 
health related quality of life; PCS = Physical Component Summary; MSC = Mental Component Summary; Physical subscale score = Chewing+Swallowing+ 
Speech+Taste+Saliva+Appearance; Social-Emotional subscale score = Anxiety+Mood+Pain+Activity+Recreation+Shoulder function)  
 
 
 
Table 5 Summary of psychometric properties of identified PROMs in clinical studies of 
patients with OLP 
Authors PROMs Questionnaire 
language/country 
Main Methods of 
Evaluation 
No of 
patients Major reported outcomes 
Hegarty et al, 
2002 (40) 
OHIP-14 English/UK Convergent validity 
(correlation with VAS for 
pain), Discriminant validity 
between patients with 
symptomatic and 
asymptomatic lesions, 
Internal consistency 
48 Correlation with VAS for pain:  
r = 0.44, p < 0.01; Significant 
difference in OHIP-14 scores 
between patients with 
symptomatic and asymptomatic 
lesions; Cronbach's α = 0.90  
 OHQOL-
UK 
English/UK Convergent validity 
(correlation with VAS for 
pain), Discriminant validity 
between patients with 
symptomatic and 
asymptomatic lesions, 
Internal consistency 
48 Correlation with VAS for pain:  
r = 0.43, p < 0.01; Significant 
difference in OHIP-14 scores 
between patients with 
symptomatic and asymptomatic 
lesions; Cronbach's α = 0.93 
McGrath et al,  
2003 (33) 
OHIP-14 English/UK Responsiveness to change 48 Significant postintervention  
change in OHIP scores (P = 
0.036) 
 OHQOL-
UK 
English/UK Responsiveness to change 48 Significant postintervention  
change in OHIP scores (P = 
0.003) 
Chainani-Wu et 
al, 2008 (18) 
VAS for  
  
symptoms 
English/USA Concurrent validity 
(correlation with other 
PROMs measuring 
symptoms), Construct validity 
(with clinical sign scores) 
33 Strong correlation between VAS 
and NRS scores (r > 0.9, P < 
0.001) at each visit; Good 
correlation between difference in 
VAS scores from previous visit 
and CSS; mild to moderate 
correlation with MOMI scores 
 NRS for  
  
symptoms 
English/USA Concurrent validity 
(correlation with other 
PROMs measuring 
symptoms), Construct validity 
(with clinical sign scores) 
33 Strong correlation between VAS 
and NRS scores (r > 0.9, P < 
0.001) at each visit; Good 
correlation between difference in 
VAS scores from previous visit 
and CSS; mild to moderate 
correlation with MOMI scores 
(stronger than VAS for 
symptoms) 
 CSS English/USA Concurrent validity 
(correlation with other 
PROMs measuring 
symptoms), Construct validity 
(with clinical sign scores) 
33 Good correlation between CSS 
scores and difference in 
VAS/NRS from previous visit; 
Low to high correlation with 
change in MOMI scores 
Ni Riordain and  
McCreary, 
2011 (41) 
COMDQ English/Ireland Convergent validity 
(correlation with VAS for pain 
and OHIP-14), Discriminant 
validity between patients with 
and without COMD, Internal 
consistency 
109 Good convergent validity with 
VAS for pain (r = 0.883) and 
OHIP-14 (r = 0.819); Significant 
difference in COMDQ scores 
between patients with  and 
without COMD; Cronbach's α = 
0.929 
Ni Riordain and  
McCreary, 
2012 (42) 
COMDQ English/Ireland Test-retest reliability,  
Responsiveness to change  
76 Good test-retest reliability  
(ICC = 0.81); COMDQ is 
responsive to changes in the 
patient's overall conditions 
Li and He, 
2013 (43) 
COMDQ Chinese/China Structural validity; Internal  
consistency; Test-retest 
reliability 
72 EFA extracted four factors  
(consistent with original english 
version) and all items 
demonstrated adequate factor 
loadings; Cronbach's α = 0.894; 
ICC of total COMDQ scores = 
0.83 
Ni Riordain et 
al, 2016 (44) 
COMDQ English/UK Convergent validity 
(correlation with VAS and 
OHIP-14), Internal 
consistency  
100 Moderate to good convergent 
validity with VAS and OHIP-14; 
Cronbach's α = 0.93 
Abbreviation: COMD = chronic oral mucosal disease; EFA = exploratory factor analysis; ICC =  intraclass  
                       correlation coefficient; MOMI = Modified Oral Mucositis Index 
Figure 1.  Flow chart showing database search results and number and types of 
included studies  
 
 
 
